Haemonetics (HAE) Accounts Payables (2010 - 2026)

Haemonetics has reported Accounts Payables for 17 years, with the latest figure at $56.3 million in Q2 2026.

• On a quarterly basis, Accounts Payables rose 22.45% year-over-year to $56.3 million in Q2 2026; TTM through Jun 2026 was $56.3 million, a 22.45% increase from a year earlier, with the FY2026 full-year figure at $51.1 million, down 23.8% from the prior year.
• Accounts Payables was $56.3 million for Q2 2026 at Haemonetics, up from $51.1 million in the prior quarter.
• The five-year high for Accounts Payables was $80.2 million in Q3 2023, with the low at $46.0 million in Q2 2025.
• Average Accounts Payables over 5 years is $62.4 million, with a median of $61.7 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2025: Accounts Payables jumped 36.73% in 2022, then slumped 40.19% in 2025.
• Over 5 years, Accounts Payables stood at $63.8 million in 2022, then retreated by 10.86% to $56.8 million in 2023, then rose by 10.81% to $63.0 million in 2024, then retreated by 22.7% to $48.7 million in 2025, then increased by 15.7% to $56.3 million in 2026.
• The last three Accounts Payables figures came in at $56.3 million (Q2 2026), $51.1 million (Q1 2026), and $48.7 million (Q4 2025), per Business Quant data.